Nonsteroidal anti-inflammatory drugs (NSAIDs) have chemopreventive benefits in both animals and humans, including against murine squamous cell carcinomas, human precancerous skin lesions, and human squamous cell carcinomas. Investigators tested the effect of the COX2-specific inhibitor celecoxib (Celebrex) in Ptch+/- mice and in 60 patients with basal cell nevus syndrome (also known as Gorlin syndrome) — an analysis spanning cage to clinic.
Genetic deletion of the COX2 gene in Ptch+/- mice exposed to UV radiation reduced the BCC tumor burden by 75%, suggesting that inhibition of COX enzyme activity could ameliorate tumor development. When Ptch+/- mice were fed celecoxib, the tumor burden was also reduced, albeit at a lower rate (35%). Two ot…
Reviewing Author
DisclosuresConsultant / advisory board Lubax; WorldCare Clinical
EquityLubax
Grant / Research support NIH; Department of Defense; American Skin Association; Piramal
Editorial boardsBritish Journal of Dermatology; Journal of the American Academy of Dermatology; Journal of Investigative Dermatology
Leadership positions in professional societies American Academy of Dermatology (Chair, Skin Cancer and Melanoma Committee); American Board of Dermatology (Director)
DisclosuresConsultant / advisory board Lubax; WorldCare Clinical
EquityLubax
Grant / Research support NIH; Department of Defense; American Skin Association; Piramal
Editorial boardsBritish Journal of Dermatology; Journal of the American Academy of Dermatology; Journal of Investigative Dermatology
Leadership positions in professional societies American Academy of Dermatology (Chair, Skin Cancer and Melanoma Committee); American Board of Dermatology (Director)